The extract and the purified compounds were cultured and tested against T. b. brucei, and T. congolense exactly as described previously, using a resazurin-based assay [16 (link),17 (link)]. The T. b. brucei strains were a standard drug-sensitive lab strain, Lister 427 (wild-type) [47 (link)] and the derived cell line B48 was developed from the wild-type by gene deletion of the drug transporter TbAT1 followed by in vitro adaptation to pentamidine [48 (link)], leading to the further loss of the gene encoding TbAQP2 [49 (link)], rendering it highly resistant to the diamidine and melaminophenyl arsenical classes of trypanocides. The T. congolense strains were the lab strain IL3000 and its diminazene-adapted clone 6C3 [50 (link)]. All EC50 values presented are the average of at least three independent determinations.
Free full text: Click here